[HTML][HTML] Intratumoural microbiota: a new frontier in cancer development and therapy

Y Cao, H Xia, X Tan, C Shi, Y Ma, D Meng… - … and Targeted Therapy, 2024 - nature.com
Human microorganisms, including bacteria, fungi, and viruses, play key roles in several
physiological and pathological processes. Some studies discovered that tumour tissues …

[HTML][HTML] Combinatorial approaches for cancer treatment using oncolytic viruses: projecting the perspectives through clinical trials outcomes

A Malogolovkin, N Gasanov, A Egorov, M Weener… - Viruses, 2021 - mdpi.com
Recent cancer immunotherapy breakthroughs have fundamentally changed oncology and
revived the fading hope for a cancer cure. The immune checkpoint inhibitors (ICI) became …

[HTML][HTML] Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review

M Li, M Zhang, Q Ye, Y Liu, W Qian - Cancer biology & medicine, 2023 - ncbi.nlm.nih.gov
Oncolytic virotherapy has emerged as a promising treatment for human cancers owing to an
ability to elicit curative effects via systemic administration. Tumor cells often create an …

[HTML][HTML] Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy

X Wang, Y Shen, X Wan, X Hu, WQ Cai, Z Wu… - Journal of Translational …, 2023 - Springer
Background Oncolytic virotherapy (OVT) is a promising anti-tumor modality that utilizes
oncolytic viruses (OVs) to preferentially attack cancers rather than normal tissues. With the …

[HTML][HTML] Evaluating the quality of studies reporting on clinical applications of stromal vascular fraction: A systematic review and proposed reporting guidelines (CLINIC …

MY Ferreira, JCC Junior, LM Ferreira - Regenerative Therapy, 2023 - Elsevier
Background The stromal vascular fraction (SVF) has been widely explored in a number of
therapeutic applications in several specialties. Its therapeutic potential is being increasingly …

[HTML][HTML] Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?

VA Naumenko, AA Stepanenko, AV Lipatova… - Molecular Therapy …, 2022 - cell.com
Oncolytic viruses are designed to specifically target cancer cells, sparing normal cells.
Although numerous studies demonstrate the ability of oncolytic viruses to infect a wide range …

[HTML][HTML] Therapeutic potential of oncolytic viruses in the era of precision oncology

M Kingsak, T Meethong, J Jongkhumkrong… - Biomaterials …, 2023 - ncbi.nlm.nih.gov
Oncolytic virus (OV) therapy has been shown to be an effective targeted cancer therapy
treatment in recent years, providing an avenue of treatment that poses no damage to …

[HTML][HTML] Oncolytic viral vectors in the era of diversified cancer therapy: From preclinical to clinical

C Tang, L Li, T Mo, J Na, Z Qian, D Fan, X Sun… - Clinical and …, 2022 - Springer
With the in-depth research and wide application of immunotherapy recently, new therapies
based on oncolytic viruses are expected to create new prospects for cancer treatment via …

[HTML][HTML] Oncolytic viruses in combination therapeutic approaches with epigenetic modulators: Past, present, and future perspectives

A Chianese, B Santella, A Ambrosino, D Stelitano… - Cancers, 2021 - mdpi.com
Simple Summary Cancer rates have been accelerating significantly in recent years. Despite
notable advances having been made in cancer therapy, and numerous studies being …

[HTML][HTML] Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters

R Kulkarni, WC Chen, Y Lee, CF Kao, SL Hu, HH Ma… - PLoS …, 2021 - journals.plos.org
COVID-19 in humans is caused by Severe acute respiratory syndrome coronavirus-2 (SARS-
CoV-2) that belongs to the beta family of coronaviruses. SARS-CoV-2 causes severe …